Celltrion Commences Full-Scale CMO Production at U.S. Facility

This marks a significant step in Celltrion's U.S. expansion and manufacturing strategy. By commencing production at the acquired Branchburg facility, Celltrion is enhancing its operational capabilities in a key market. The parallel validation for its own products signals a move towards greater self-sufficiency and a more integrated supply chain within the U.S. This proactive approach, including structural mitigation of tariff risks through local production, is crucial for maintaining business continuity and safeguarding shareholder value amidst potential U.S. trade policy shifts. The ability to supply locally manufactured products directly to the U.S. market strengthens Celltrion's competitive position and reduces reliance on imports, which is particularly relevant for APAC companies looking to expand their global footprint and navigate international trade complexities.